The Netherlands bans private stem cell therapyBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39072.458449.DB (Published 04 January 2007) Cite this as: BMJ 2007;334:12
- Tony Sheldon
The Dutch government has banned the “clinical application” of controversial stem cell therapy being offered by private clinics in the Netherlands for conditions such as amyotrophic lateral sclerosis and multiple sclerosis.
The ban has been imposed as part of a new regulation on the transplantation of stem cells governing the way in which they are used to regenerate different tissue and organs—for example, in the heart, liver, or kidneys.
The ministry of health describes such therapy as “promising,” with “possible applications” in the future for Parkinson's …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial